Oct 26, 2023 / 06:00PM GMT
Operator
Good evening, and welcome to this investor update and Q&A with 2cureX. With us today, we have the management team, represented by the CEO, CSO and CFO. First, there will be a presentation and afterwards a Q&A, where the management team will answer questions submitted via Stokk.io. They have already been pre-submitted many questions on Stokk.io for the Q&A, which we appreciate. The Q&A is still open so that you can submit questions live as well. I will now hand over the mic to 2cureX for the live presentation. Your line is now open.
Fernando Andreu - 2cureX AB(publ)-CEO
Yes. Thank you, Anders, and good evening, everybody. Yes, this is the agenda that we are going to cover today. I'm going to speak about the development of our commercial pipeline, as we have done in the previous quarters; then the preliminary Q3 results based on the goals that we have published; and then we will focus in the strategy update. There will be a few comments about our strategy update that we have released a press release this afternoon.
Q3 2023 2cureX AB Earnings Call Transcript
Mar 01, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers